The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial…

RT @cvirendo: Here's a throwback article on the CLEAR survey: an international perspective on antiplatelet and anticoagulant practice for p…

RT @cvirendo: Here's a throwback article on the CLEAR survey: an international perspective on antiplatelet and anticoagulant practice for p…

RT @cvirendo: Here's a throwback article on the CLEAR survey: an international perspective on antiplatelet and anticoagulant practice for p…

RT @cvirendo: Here's a throwback article on the CLEAR survey: an international perspective on antiplatelet and anticoagulant practice for p…

Here's a throwback article on the CLEAR survey: an international perspective on antiplatelet and anticoagulant practice for peripheral #arterial #endovascular intervention 🚀 https://t.co/XsNpaE1s15 @davebosanquet @kittywonghf @robhinchliffe1 @DrMahim #ira

The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention https://t.co/yuL0Sk5vGd

RT @cvirendo: More than one year after publication and the article is still going strong. More than 2k downloads 👏🚀 #irad #openaccess

RT @cvirendo: More than one year after publication and the article is still going strong. More than 2k downloads 👏🚀 #irad #openaccess

RT @cvirendo: More than one year after publication and the article is still going strong. More than 2k downloads 👏🚀 #irad #openaccess http…

RT @cvirendo: More than one year after publication and the article is still going strong. More than 2k downloads 👏🚀 #irad #openaccess http…

RT @cvirendo: More than one year after publication and the article is still going strong. More than 2k downloads 👏🚀 #irad #openaccess

More than one year after publication and the article is still going strong. More than 2k downloads 👏🚀 #irad #openaccess

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @ozvascdoc: Clinical equipoise exists for a prospective trial on antithrombotic use with peripheral endovascular therapy. Great example…

RT @davebosanquet: Exactly 3 weeks since the @VascResearchNet #CLEARsurvey has been published in @cvirendo. Approx 1k downloads since thi…

RT @davebosanquet: Exactly 3 weeks since the @VascResearchNet #CLEARsurvey has been published in @cvirendo. Approx 1k downloads since thi…

RT @davebosanquet: Exactly 3 weeks since the @VascResearchNet #CLEARsurvey has been published in @cvirendo. Approx 1k downloads since thi…

Exactly 3 weeks since the @VascResearchNet #CLEARsurvey has been published in @cvirendo. Approx 1k downloads since this time! Big impact from this important piece of #collaborative work. https://t.co/6Pu8z3TsL7 https://t.co/hqyG7Zoapu

@robhinchliffe1 @JACCJournals @AboyansV @MelVegCen @YaleVascular @Vascupedia_com @CVIR_Journal @EVToday @EndovascularU @MCWVascSurg We do not know! https://t.co/jbE24Nu4cH

@EndovascularU @JACCJournals @AboyansV @cvirendo @MelVegCen @YaleVascular @Vascupedia_com @CVIR_Journal @EVToday @MCWVascSurg That cocktail doesn’t appear to be in regular use. https://t.co/M9wCxLpZFB

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

RT @robhinchliffe1: Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work fro…

Major variations in antiplatelet regimes following lower limb angioplasty. https://t.co/M9wCxLpZFB. More great work from @VascResearchNet @kittywonghf https://t.co/Ncjs5y4ruh

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

Clinical equipoise exists for a prospective trial on antithrombotic use with peripheral endovascular therapy. Great example of collaborative global research using the @VascResearchNet model. Happy to be part of this work. @anzsvs @anzvtn @TobyRichardsUWA

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

RT @JJEarnshaw: Watch for the umbrella review of meta-analyses on antiplatelets for PAD in the January @BJSurgery and available online immi…

RT @cvirendo: Antiplatelet and anticoagulant therapy are commonly used in peripheral #arterial interventions. There is a widespread variati…

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

RT @JJEarnshaw: Watch for the umbrella review of meta-analyses on antiplatelets for PAD in the January @BJSurgery and available online immi…

RT @CSR_Bris: Excellent collaborative work on 2 publications. The CLEAR survey 👉https://t.co/5dVdTSs93v The PLACEMENT trial 👉 https://t.c…

RT @CSR_Bris: Excellent collaborative work on 2 publications. The CLEAR survey 👉https://t.co/5dVdTSs93v The PLACEMENT trial 👉 https://t.c…

RT @CSR_Bris: Excellent collaborative work on 2 publications. The CLEAR survey 👉https://t.co/5dVdTSs93v The PLACEMENT trial 👉 https://t.c…

RT @CSR_Bris: Excellent collaborative work on 2 publications. The CLEAR survey 👉https://t.co/5dVdTSs93v The PLACEMENT trial 👉 https://t.c…

Excellent collaborative work on 2 publications. The CLEAR survey 👉https://t.co/5dVdTSs93v The PLACEMENT trial 👉 https://t.co/P9FaY9eInb @kittywonghf @davebosanquet @GraemeAmbler @DrMahim @robhinchliffe1 @Waldron_CA @emma_tj1 @LBrookesHowell @MarkKelson @

RT @cvirendo: Antiplatelet and anticoagulant therapy are commonly used in peripheral #arterial interventions. There is a widespread variati…

RT @JJEarnshaw: Watch for the umbrella review of meta-analyses on antiplatelets for PAD in the January @BJSurgery and available online immi…

RT @JJEarnshaw: Watch for the umbrella review of meta-analyses on antiplatelets for PAD in the January @BJSurgery and available online immi…

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

Watch for the umbrella review of meta-analyses on antiplatelets for PAD in the January @BJSurgery and available online imminently

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

#CLEARSurvey showcases how @VascResearchNet is changing/streamlining the development pathway towards large scale randomised research #RCT in vascular surgery @VSGBI @Vascupedia_com @robhinchliffe1

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

RT @davebosanquet: Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular the…

Superb collaborative effort to produce this important piece of work on #antiplatelet prescription after endovascular therapy. Made possible with support from @VascResearchNet and @cvirendo. Full paper at https://t.co/6Pu8z3TsL7 #CLEARsurvey #collaborat

RT @cvirendo: Antiplatelet and anticoagulant therapy are commonly used in peripheral #arterial interventions. There is a widespread variati…

RT @cvirendo: Antiplatelet and anticoagulant therapy are commonly used in peripheral #arterial interventions. There is a widespread variati…

Antiplatelet and anticoagulant therapy are commonly used in peripheral #arterial interventions. There is a widespread variation in use but no good evidence. There is support for a randomised trial: https://t.co/XsNpaDJQCv #irad #FOAMed https://t.co/LX7w9r4